Literature DB >> 8758050

Thyrotoxic periodic paralysis in a Chinese population.

G T Ko1, C C Chow, V T Yeung, H H Chan, J K Li, C S Cockram.   

Abstract

We retrospectively evaluated the characteristics of adult patients admitted with thyrotoxic hypokalaemic periodic paralysis in Hong Kong. From 1984 to 1993, 45 Chinese adult patients were admitted with acute limb weakness, plasma potassium < or = 3.5 mmol/l and thyrotoxicosis confirmed by laboratory investigations. All but one were male. Seventy-five percent of attacks occurred between 9pm and 9am. Half of the attacks occurred between July and October (49.1%), most commonly in August (20%). Mean (+/- SEM) plasma potassium on admission was 2.17 +/- 0.08 mmol/l (range 1.1-3.5). In 15 episodes (27.3%), plasma potassium on recovery exceeded 5.0 mmol/l, while in three episodes (5.5%), potassium exceeded 6.0 mmol/l. No patient had a positive family history of thyrotoxic periodic paralysis. Only 28.9% had a known history of thyrotoxicosis before their first presentation with periodic paralysis. Twenty-seven (60%) had clinical evidence of thyrotoxicosis. Although all were biochemically thyrotoxic, 11.4% had only a mild degree of thyrotoxicosis (suppressed thyroid-stimulating hormone, high free thyroxine, but normal free triiodothyronine). One quarter of the patients had a normal erythrocyte zinc concentration, indicating either a short history of thyrotoxicosis or transient thyrotoxicosis. The diagnosis of thyrotoxic hypokalaemic paralysis should always be considered in Chinese patients with acute muscle weakness, especially in young males. Absence of clinical thyrotoxicosis does not exclude the diagnosis. Plasma potassium should be monitored carefully during treatment to prevent rebound hyperkalaemia.

Entities:  

Mesh:

Year:  1996        PMID: 8758050     DOI: 10.1093/qjmed/89.6.463

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  21 in total

1.  Sudden weakness in a young Chinese man.

Authors:  V R Kodali; B Jeffcote; R B Clague
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

Review 2.  Novel etiopathophysiological aspects of thyrotoxic periodic paralysis.

Authors:  Rui M B Maciel; Susan C Lindsey; Magnus R Dias da Silva
Journal:  Nat Rev Endocrinol       Date:  2011-05-10       Impact factor: 43.330

Review 3.  Thyrotoxic periodic paralysis: clinical and molecular aspects.

Authors:  Henrik Falhammar; Marja Thorén; Jan Calissendorff
Journal:  Endocrine       Date:  2012-08-24       Impact factor: 3.633

4.  Pituitary macroadenoma: a rare cause of thyrotoxic hypokalaemic periodic paralysis.

Authors:  Soumik Ghosh; Ratnakar Sahoo; Sachin Rao; Deepak Rath
Journal:  BMJ Case Rep       Date:  2013-02-06

5.  Thyrotoxic Periodic Paralysis: Case Reports and an Up-to-Date Review of the Literature.

Authors:  Abbi Lulsegged; Christina Wlodek; Michela Rossi
Journal:  Case Rep Endocrinol       Date:  2011-09-22

6.  Thyrotoxic periodic paralysis associated with transient thyrotoxicosis due to painless thyroiditis.

Authors:  Sang Bo Oh; Jinhee Ahn; Min Young Oh; Bo Gwang Choi; Ji Hyun Kang; Yun Kyung Jeon; Sang Soo Kim; Bo Hyun Kim; Yong Ki Kim; In Joo Kim
Journal:  J Korean Med Sci       Date:  2012-06-29       Impact factor: 2.153

7.  A rare case of paralysis in an endemic area.

Authors:  Bulent Yardimci; Rumeyza Kazancioglu
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

8.  Levothyroxine and prednisone causing generalized weakness in a middle-aged man.

Authors:  Andrew Word; Kevin Davidson; Essam Elsayed
Journal:  Case Rep Endocrinol       Date:  2012-10-18

9.  Etiology of hypokalemic paralysis in Korea: data from a single center.

Authors:  Jung-Kook Wi; Hong Joo Lee; Eun Young Kim; Joo Hee Cho; Sang Ouk Chin; Sang Youl Rhee; Ju-Young Moon; Sang-Ho Lee; Kyung-Hwan Jeong; Chun-Gyoo Ihm; Tae-Won Lee
Journal:  Electrolyte Blood Press       Date:  2012-12-31

10.  Comparative study of thyrotoxic periodic paralysis from idiopathic hypokalemic periodic paralysis: An experience from India.

Authors:  J Kalita; G Goyal; S K Bhoi; S Chandra; U K Misra
Journal:  Ann Indian Acad Neurol       Date:  2012-07       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.